copyright 2018 npr. to see more, visit /www.npr.org/..
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.on saturday, may 5, with her husband beside her, helen's condition turned grave..
., and bones, and it�s not clear how the drugs will affect them after long-term use..